theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Hospital Medicine

Diffuse Parenchymal Lung Disease   

Questions discussed in this category


Would you consider using steroids in patients with respiratory failure caused by aspiration pneumonitis?
1 Answer available

What are the next steps in the management of a patient admitted with an IPF exacerbation resistant to steroid therapy?
2 Answers available
2289817162


Papers discussed in this category


The Lancet. Respiratory medicine, 2021 Sep 07
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial.

American journal of respiratory and critical care medicine, 2020 May 01
Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Randomized, Double-Blind Placebo-controlled Trial.

Chest, 2018 Jun 30
Effect of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplantation Outcome.

The European respiratory journal, 2010 Jul 01
Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome.

Transplantation, 2024 May 23
Impact of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplant Outcomes.

Related Topics in Hospital Medicine

  • Lung Cancer
  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Oncology
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers
  • Genitourinary Cancers

Copyright © 2025 theMednet
All Rights Reserved.